Shortcut Navigation:

Breast Cancer News

In this section, access cutting-edge breast cancer news on treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.

U.S. revokes approval of Avastin for breast cancer

WASHINGTON (Reuters) - U.S. drug regulators on Friday withdrew approval of Roche's Avastin as a treatment for breast cancer, capping a protracted and emotional battle over a drug backed by many survivors of the disease.

Brain scan study finds evidence of 'chemo brain'

CHICAGO (Reuters) - Women who survive breast cancer after undergoing chemotherapy may also have to contend with impairments in attention, memory and planning skills, U.S. researchers said on Monday.

Should you skip alcohol if mom had breast cancer?

NEW YORK (Reuters Health) - A team of U.S. scientists believe they have found a piece of advice that breast cancer -stricken mothers can give their daughters to help them stave off the disease: stay clear of alcohol.

Breast cancer survival gains lag in the elderly

NEW YORK (Reuters Health) - Although fewer and fewer women have died of breast cancer each year over the past two decades, a new study suggests that improvements in survival have been slowest for the oldest women with the disease.

Tamoxifen Reduces ER-positive Recurrence Rate

In a five-year review of 20 clinical trials, tamoxifen was shown to safely reduce both 15-year risk for recurrence and death in early-stage estrogen receptor-positive breast cancer.

Breast cancer risk: It's not all in the family

CHICAGO (Reuters) - Women do not automatically have a higher risk of getting breast cancer just because someone else in the family has tested positive for breast cancer genes, U.S. researchers said Monday.

Doctors split on Avastin for breast cancer: survey

NEW YORK (Reuters Health) - An international survey of cancer doctors shows many question U.S. health advisers' 2010 rejection of Roche's drug Avastin to treat advanced breast cancer.

Mammogram results often wrong, U.S. study finds

CHICAGO (Reuters) - More than half of healthy women who have an annual mammogram will get at least one false positive result over a 10-year period, and 7 to 9 percent will undergo a biopsy that doesn't turn out to show cancer, according to U.S. researchers.

Antioxidants tied to mixed effects in breast cancer

NEW YORK (Reuters Health) - Breast cancer patients who take antioxidants may have an increased or decreased risk of death or recurrent cancer, depending on which vitamin they use, a new study suggests.

Breast cancer drug tied to diabetes in older women

NEW YORK (Reuters Health) - Older women taking the breast cancer drug tamoxifen may have an increased risk of developing diabetes, a new study suggests.

Join Your Community for Yoga on the Steps!

Close
close